United Therapeutics Debt to Equity Ratio 2006-2018 | UTHR

Current and historical debt to equity ratio values for United Therapeutics (UTHR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. United Therapeutics debt/equity for the three months ending September 30, 2018 was 0.09.
United Therapeutics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.25B $2.69B 0.09
2018-06-30 $0.25B $2.57B 0.10
2018-03-31 $0.25B $2.37B 0.11
2017-12-31 $0.25B $2.10B 0.12
2017-09-30 $0.00B $2.07B 0.00
2017-06-30 $0.00B $1.78B 0.00
2017-03-31 $0.00B $2.07B 0.00
2016-12-31 $0.00B $1.85B 0.00
2016-09-30 $0.00B $1.84B 0.00
2016-06-30 $0.00B $1.81B 0.00
2016-03-31 $0.00B $1.71B 0.00
2015-12-31 $0.00B $1.59B 0.00
2015-09-30 $0.00B $1.47B 0.00
2015-06-30 $0.00B $1.04B 0.00
2015-03-31 $0.00B $1.09B 0.00
2014-12-31 $0.00B $1.24B 0.00
2014-09-30 $0.00B $1.18B 0.00
2014-06-30 $0.00B $1.17B 0.00
2014-03-31 $0.00B $1.32B 0.00
2013-12-31 $0.00B $1.26B 0.00
2013-09-30 $0.00B $1.26B 0.00
2013-06-30 $0.00B $1.17B 0.00
2013-03-31 $0.21B $1.15B 0.18
2012-12-31 $0.28B $1.08B 0.25
2012-09-30 $0.20B $1.06B 0.19
2012-06-30 $0.20B $1.01B 0.20
2012-03-31 $0.27B $1.03B 0.26
2011-12-31 $0.27B $0.95B 0.28
2011-09-30 $0.07B $1.09B 0.06
2011-06-30 $0.07B $1.00B 0.07
2011-03-31 $0.07B $0.92B 0.08
2010-12-31 $0.07B $0.88B 0.08
2010-09-30 $0.00B $0.84B 0.00
2010-06-30 $0.00B $0.78B 0.00
2010-03-31 $0.03B $0.73B 0.04
2009-12-31 $0.03B $0.65B 0.05
2009-09-30 $0.03B $0.64B 0.05
2009-06-30 $0.24B $0.61B 0.40
2009-03-31 $0.24B $0.58B 0.41
2008-12-31 $0.24B $0.56B 0.42
2008-09-30 $0.03B $0.42B 0.07
2008-06-30 $0.00B $0.36B 0.00
2008-03-31 $0.23B $0.33B 0.70
2007-12-31 $0.00B $0.30B 0.00
2007-09-30 $0.25B $0.21B 1.19
2007-06-30 $0.25B $0.18B 1.40
2007-03-31 $0.25B $0.15B 1.65
2006-12-31 $0.25B $0.21B 1.22
2006-09-30 $0.00B $0.28B 0.00
2006-06-30 $0.00B $0.30B 0.00
2006-03-31 $0.00B $0.29B 0.00
2005-12-31 $0.00B $0.28B 0.00
2005-09-30 $0.00B $0.24B 0.00
2005-06-30 $0.00B $0.22B 0.00
2005-03-31 $0.00B $0.20B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.935B $1.725B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.572B 11.48
Zoetis (ZTS) United States $42.477B 29.08
Grifols (GRFS) Spain $14.128B 17.24
Tilray (TLRY) United States $9.687B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.785B 12.61
Neurocrine Biosciences (NBIX) United States $8.024B 1769.80
Ionis Pharmaceuticals (IONS) United States $7.331B 0.00
Nektar Therapeutics (NKTR) United States $6.598B 9.46
Impax Laboratories (AMRX) United States $5.553B 29.52
Catalent (CTLT) United States $5.466B 22.93
Sage Therapeutics (SAGE) United States $5.035B 0.00
Loxo Oncology (LOXO) United States $4.516B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.906B 14.46
FibroGen (FGEN) United States $3.346B 0.00
USANA Health Sciences (USNA) United States $2.872B 24.44
Endo (ENDP) Ireland $2.811B 4.31
TESARO (TSRO) United States $2.338B 0.00
Xencor (XNCR) United States $2.113B 0.00
Endocyte (ECYT) United States $1.935B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.888B 255.06
Aerie Pharmaceuticals (AERI) United States $1.866B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.838B 0.00
Heron Therapeutics (HRTX) United States $1.816B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.755B 0.00
Zogenix (ZGNX) United States $1.692B 0.00
PTC Therapeutics (PTCT) United States $1.619B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.552B 18.97
Corcept Therapeutics (CORT) United States $1.415B 20.76
Theravance Biopharma (TBPH) Cayman Islands $1.374B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.360B 0.00
Portola Pharmaceuticals (PTLA) United States $1.281B 0.00
Esperion Therapeutics (ESPR) United States $1.225B 0.00
Tricida (TCDA) United States $1.221B 0.00
TherapeuticsMD (TXMD) United States $1.149B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.083B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.954B 0.00
ImmunoGen (IMGN) United States $0.796B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.730B 0.00
Radius Health (RDUS) United States $0.706B 0.00
Karyopharm Therapeutics (KPTI) United States $0.620B 0.00
Flexion Therapeutics (FLXN) United States $0.596B 0.00
Collegium Pharmaceutical (COLL) United States $0.570B 0.00
GlycoMimetics (GLYC) United States $0.510B 0.00
ChemoCentryx (CCXI) United States $0.482B 38.12
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.452B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.435B 0.00
Dermira (DERM) United States $0.425B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Xeris Pharmaceuticals (XERS) United States $0.412B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.409B 24.13
Forty Seven (FTSV) United States $0.397B 0.00
Akebia Therapeutics (AKBA) United States $0.396B 0.00
Odonate Therapeutics (ODT) United States $0.395B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.387B 0.00
OptiNose (OPTN) United States $0.386B 0.00
ArQule (ARQL) United States $0.386B 0.00
CASI Pharmaceuticals (CASI) United States $0.379B 0.00
Aclaris Therapeutics (ACRS) United States $0.351B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Zafgen (ZFGN) United States $0.343B 0.00
Depomed (ASRT) United States $0.343B 12.76
KalVista Pharmaceuticals (KALV) United States $0.340B 0.00
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Minerva Neurosciences (NERV) United States $0.327B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.317B 0.00
Translate Bio (TBIO) United States $0.316B 0.00
Aratana Therapeutics (PETX) United States $0.311B 0.00
Mast Therapeutics (SVRA) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.291B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.287B 0.00
Tapimmune (MRKR) United States $0.284B 0.00
Majesco Entertainment (PTE) United States $0.276B 0.00
Affimed (AFMD) Germany $0.267B 0.00
IMV INC (IMV) Canada $0.248B 0.00
Lannett Co Inc (LCI) United States $0.226B 1.97
Aldeyra Therapeutics (ALDX) United States $0.222B 0.00
Tyme Technologies (TYME) United States $0.221B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
Opexa Therapeutics (ACER) United States $0.210B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.210B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.206B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.199B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.193B 0.00
MEI Pharma (MEIP) United States $0.191B 0.00
Neon Therapeutics (NTGN) United States $0.180B 0.00
Calithera Biosciences (CALA) United States $0.180B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.176B 0.00
Ardelyx (ARDX) United States $0.176B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 0.00
ElectroCore (ECOR) United States $0.169B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
Redhill Biopharma (RDHL) Israel $0.162B 0.00
ContraFect (CFRX) United States $0.160B 0.00
MediWound (MDWD) Israel $0.155B 0.00
Jounce Therapeutics (JNCE) United States $0.144B 0.00
Melinta Therapeutics (MLNT) United States $0.143B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Recro Pharma (REPH) United States $0.138B 0.00
DURECT (DRRX) United States $0.135B 0.00
Adherex Technologies (FENC) United States $0.133B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.123B 0.00
ProNAi Therapeutics (SRRA) Canada $0.119B 0.00
Cardiome Pharma (CORV) Canada $0.117B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.108B 0.00
Rafael Holdings (RFL) United States $0.105B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.096B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.095B 0.00
CTI BioPharma (CTIC) United States $0.090B 0.00
Achaogen (AKAO) United States $0.090B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.084B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.079B 0.00
Infinity Pharmaceuticals (INFI) United States $0.077B 0.00
Otonomy (OTIC) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.070B 6.94
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
KemPharm (KMPH) United States $0.063B 0.00
Immune Design (IMDZ) United States $0.063B 0.00
Forward Pharma (FWP) Denmark $0.063B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 35.00
Novan (NOVN) United States $0.055B 0.00
Neos Therapeutics (NEOS) United States $0.052B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.048B 0.00
Heat Biologics (HTBX) United States $0.048B 0.00
Capnia (SLNO) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Trillium Therapeutics (TRIL) Canada $0.040B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.038B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.94
Lipocine (LPCN) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
HANCOCK JAFFE (HJLI) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 6.65
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.017B 0.00
Shineco (TYHT) China $0.016B 1.58
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Bio-Path Holdings (BPTH) United States $0.007B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
PharmAthene (ALT) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00